These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4120423)

  • 21. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [T and B lymphoid subpopulations in patients with leprosy].
    Finiasz MR; Arias DA; Valdez R; Estevez ME; Sen L
    Medicina (B Aires); 1981; 41 Suppl():131-6. PubMed ID: 7047979
    [No Abstract]   [Full Text] [Related]  

  • 23. [Leprosy serology].
    CONTRERAS DUENAS ; RODRIGO ABAD
    Fontilles Rev Leprol; 1946 Jan; ():307-18. PubMed ID: 20984720
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphoproliferation and in vitro antibody synthesis in leprosy patients.
    Yandava CN; Bhutani LK; Sharma AK; Nath I
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):633-40. PubMed ID: 2674302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of fluorescence microscopy in the diagnosis of leprosy.
    KHANOLKAR VR; NERURKAR RV
    Indian J Med Res; 1956 Jul; 44(3):397-402. PubMed ID: 13366411
    [No Abstract]   [Full Text] [Related]  

  • 26. A note on fluorescence microscopy in the diagnosis of leprosy.
    GOHAR MA
    J Trop Med Hyg; 1952 Jul; 55(7):156-7. PubMed ID: 14946851
    [No Abstract]   [Full Text] [Related]  

  • 27. Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients.
    Britton WJ; Hellqvist L; Garsia RJ; Basten A
    Clin Exp Immunol; 1988 Mar; 71(3):394-8. PubMed ID: 3289801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodeficiency in leprosy.
    Lim SD; Kiszkiss DF; Choi YS; Gajl-Peczalska K; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):244-9. PubMed ID: 1096981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings].
    Rojas-Espinosa O; Jiménez-Zamudio L; Arce-Paredes P
    Rev Latinoam Microbiol; 1994; 36(3):213-9. PubMed ID: 7709098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early events in the host-parasite relationship and immune response in clinical leprosy: its possible importance for leprosy control.
    Bjune G; Closs O; Barnetson RS
    Clin Exp Immunol; 1983 Nov; 54(2):289-97. PubMed ID: 6228348
    [No Abstract]   [Full Text] [Related]  

  • 31. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cell-mediated immunity in patients with leprosy treated with rifampicin].
    Valdés-Portela A; de la Cruz F
    Rev Cubana Med Trop; 1987; 39(3):23-32. PubMed ID: 3327106
    [No Abstract]   [Full Text] [Related]  

  • 33. B lymphocytes in primary and secondary deficiencies of humoral immunity.
    Gajl-Peczalska K; Lim SD; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):33-5. PubMed ID: 1080058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy.
    Hussain R; Dockrell HM; Chiang TJ
    Immunology; 1999 Apr; 96(4):620-7. PubMed ID: 10233750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highlights of the workshop on primary immunodeficiencies: where have we been - where are we going?
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):579-91. PubMed ID: 125123
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in immunology and biochemistry in leprosy in the next decade.
    Karat AB
    Lepr Rev; 1967 Apr; 38(2):7-101. PubMed ID: 6045743
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leucocyte migration inhibition test in leprosy patients across the spectrum of leprosy.
    Sivamani S; Garg BR; Lal S
    Lepr India; 1980 Oct; 52(4):527-31. PubMed ID: 7464058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoresititution disease in relation to infection with Mycobacterium avium complex and to leprosy.
    Phillips P
    Clin Infect Dis; 2001 Mar; 32(5):845-7. PubMed ID: 11229860
    [No Abstract]   [Full Text] [Related]  

  • 40. Production of macrophage inhibitory factor by patients with leprosy.
    Katz SI; DeBetz BH; Zaias N
    Arch Dermatol; 1971 Apr; 103(4):358-61. PubMed ID: 5091865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.